Statistics
Publications
13
Citations
2.7K
H-Index
13
Active since
2015
Alan L. Leggett is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and medicine.
Publications per year
2015–2020
13
13
The dTAG system for immediate and target-specific protein degradation
Behnam Nabet, Justin M. Roberts, Dennis L. Buckley et al. · Nature Chemical Biology · 2018 · 1.2K citations · Full text
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma
Amanda Balboni Iniguez, Björn Stolte, Emily Jue Wang et al. · Cancer Cell · 2018 · 169 citations · Full text
Medicine, Cancer Biology, Oncology +13
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
Mei Zeng, Nicholas Kwiatkowski, Tinghu Zhang et al. · eLife · 2018 · 166 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–5 of 13